The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

被引：0
|
作者：
Uzma Khan
Helena Huerga
Aamir J. Khan
Carole D. Mitnick
Catherine Hewison
Francis Varaine
Mathieu Bastard
Michael Rich
Molly F. Franke
Sidney Atwood
Palwasha Y. Khan
Kwonjune J. Seung
机构：
[1] Interactive Research and Development (IRD),Field Epidemiology Department
[2] Epicentre,Department of Global Health and Social Medicine
[3] Interactive Research and Development (IRD) Global,Medical Department
[4] Harvard Medical School,Division of Global Health Equity
[5] Médecins Sans Frontières,undefined
[6] Partners In Health,undefined
[7] Brigham and Women’s Hospital,undefined
来源：
BMC Infectious Diseases | / 19卷
关键词：
MDR-TB; Bedaquiline; Delamanid; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
    Khan, Uzma
    Huerga, Helena
    Khan, Aamir J.
    Mitnick, Carole D.
    Hewison, Catherine
    Varaine, Francis
    Bastard, Mathieu
    Rich, Michael
    Franke, Molly F.
    Atwood, Sidney
    Khan, Palwasha Y.
    Seung, Kwonjune J.
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [2] Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
    Hewison, Catherine
    Khan, Uzma
    Bastard, Mathieu
    Lachenal, Nathalie
    Coutisson, Sylvine
    Osso, Elna
    Ahmed, Saman
    Khan, Palwasha
    Franke, Molly F.
    Rich, Michael L.
    Varaine, Francis
    Melikyan, Nara
    Seung, Kwonjune J.
    Adenov, Malik
    Adnan, Sana
    Danielyan, Narine
    Islam, Shirajul
    Janmohamed, Aleeza
    Karakozian, Hayk
    Kimenye, Maureen Kamene
    Kirakosyan, Ohanna
    Kholikulov, Begimkul
    Krisnanda, Aga
    Kumsa, Andargachew
    Leblanc, Garmaly
    Lecca, Leonid
    Nkuebe, Mpiti
    Mamsa, Shahid
    Padayachee, Shrivani
    Thit, Phone
    Mitnick, Carole D.
    Huerga, Helena
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (06) : 1006 - 1013
  • [3] Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial
    Cellamare, M.
    Milstein, M.
    Ventz, S.
    Baudin, E.
    Trippa, L.
    Mitnick, C. D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S8 - S12
  • [4] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
    Koirala, S.
    Borisov, S.
    Danila, E.
    Mariandyshev, A.
    Shrestha, B.
    Lukhele, N.
    Dalcolmo, M.
    Shakya, S. R.
    Miliauskas, S.
    Kuksa, L.
    Manga, S.
    Aleksa, A.
    Denholm, J. T.
    Khadka, H. B.
    Skrahina, A.
    Diktanas, S.
    Ferrarese, M.
    Bruchfeld, J.
    Koleva, A.
    Piubello, A.
    Koirala, G. S.
    Udwadia, Z. F.
    Palmero, D. J.
    Munoz-Torrico, M.
    Gc, R.
    Gualano, G.
    Grecu, V., I
    Motta, I
    Papavasileiou, A.
    Li, Y.
    Hoefsloot, W.
    Kunst, H.
    Mazza-Stalder, J.
    Payen, M-C
    Akkerman, O. W.
    Bernal, E.
    Manfrin, V
    Matteelli, A.
    Hamdan, H. Mustafa
    Marcos, M. Nieto
    Cadinanos Loidi, J.
    Cebrian Gallardo, J. J.
    Duarte, R.
    Escobar Salinas, N.
    Gomez Rosso, R.
    Laniado-Laborin, R.
    Martinez Robles, E.
    Quiros Fernandez, S.
    Rendon, A.
    Solovic, I
    PULMONOLOGY, 2021, 27 (05): : 403 - 412
  • [5] Bedaquiline-containing regimens for MDR TB treatment - Focus on the safety
    Borisov, Sergey
    Filippov, Alexsey
    Ivanushkina, Taisiya
    Ivanova, Diana
    Litvinova, Nataliya
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [6] Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study
    Gao, M.
    Gao, J.
    Xie, L.
    Wu, G.
    Chen, W.
    Chen, Y.
    Pei, Y.
    Li, G.
    Liu, Y.
    Shu, W.
    Fan, L.
    Wu, Q.
    Du, J.
    Chen, X.
    Tang, P.
    Xiong, Y.
    Li, M.
    Cai, Q.
    Jin, L.
    Mei, Z.
    Pang, Y.
    Li, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (04) : 597 - 602
  • [7] Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
    Borisov, Sergey E.
    Dheda, Keertan
    Enwerem, Martin
    Leyet, Rodolfo Romero
    D'Ambrosio, Lia
    Centis, Rosella
    Sotgiu, Giovanni
    Tiberi, Simon
    Alffenaar, Jan-Willem
    Maryandyshev, Andrey
    Belilovski, Evgeny
    Ganatra, Shashank
    Skrahina, Alena
    Akkerman, Onno
    Aleksa, Alena
    Amale, Rohit
    Artsukevich, Janina
    Bruchfeld, Judith
    Caminero, Jose A.
    Carpena Martinez, Isabel
    Codecasa, Luigi
    Dalcolmo, Margareth
    Denholm, Justin
    Douglas, Paul
    Duarte, Raquel
    Esmail, Aliasgar
    Fadul, Mohammed
    Filippov, Alexey
    Forsman, Lina Davies
    Gaga, Mina
    Garcia-Fuertes, Julia-Amaranta
    Garcia-Garcia, Jose-Maria
    Gualano, Gina
    Jonsson, Jerker
    Kunst, Heinke
    Lau, Jillian S.
    Mastrapa, Barbara Lazaro
    Troya, Jorge Lazaro Teran
    Manga, Selene
    Manika, Katerina
    Gonzalez Montaner, Pablo
    Mullerpattan, Jai
    Oelofse, Suzette
    Ortelli, Martina
    Juan Palmero, Domingo
    Palmieri, Fabrizio
    Papalia, Antonella
    Papavasileiou, Apostolos
    Payen, Marie-Christine
    Pontali, Emanuele
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [8] Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
    Field, Stephen K.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 137 - 149
  • [9] Cost-effectiveness of treating MDR-TB by adding delamanid to background regimens in Germany
    Diel, Roland
    Hittel, Norbert
    Schaberg, Tom
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
    Weng, Taoping
    Sun, Feng
    Li, Yang
    Chen, Jiazhen
    Chen, Xinchang
    Li, Rong
    Ge, Shijia
    Zhao, Yanlin
    Zhang, Wenhong
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
12345